跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Abetol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Abetol
Approved
STANDARD
Abetol
Swiss Parenterals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3571266ec348b395
Company
Swiss Parenterals Ltd.
Type
Standard
Approval Details
Approval Id
3571266ec348b395
Drug Approval Philippines Name
Abetol
Product Name
Abetol
Registration Number
DR-XY43857
Brand Name
Abetol
Generic Name
Labetalol hydrochloride
Dosage Form
Solution for Injection (IV)
Dosage Strength
5 mg/mL (100 mg/20 mL)
Manufacturer
Swiss Parenterals Ltd.
Importer
Endure Medical, Inc.
Issuance Date
25 July 2024
Expiry Date
07 November 2029
Pharmacologic Category
Alpha and Beta Blocking Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3571266ec348b395
Type
Standard
Back to Philippines FDA Approvals